Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Cimalgex   
Auth. number : EU/2/10/119
Active substance : Cimicoxib
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AH - Coxibs
Chemical substance: QM01AH93 - cimicoxib
(See WHO ATCvet Index)
Indication: For the treatment of pain and inflammation associated with osteoarthritis, and the management of peri-operative pain due to orthopaedic or soft tissue surgery, in dogs.
Marketing Authorisation Holder: Vétoquinol SA
Magny-Vernois, 70200 Lure, France
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/02/2011 Centralised - Authorisation EMEA/V/C/162 (2011)1151 of 18/02/2011
23/08/2015 Centralised - Variation EMEA/V/C/162/IB/1
Updated with Decision(2016)73 of 07/01/2016
11/01/2016 Centralised - Renewal EMEA/V/C/162/R/2 (2016)73 of 7/01/2016